Evaluation of in vitro storage properties of prestorage pooled whole blood-derived platelets suspended in 100 percent plasma and treated with amotosalen and long-wavelength ultraviolet light

Transfusion

Volumn 49, Issue 4, 2009, Pages 704-710

  Wagner, Stephen J ^a   Skripchenko, Andrey ^b   Myrup, Andrew ^b   Awatefe, Helen ^b   Thompson Montgomery, Dedeene ^b   Moroff, Gary ^b   Carmichael, Patrick ^b   Lin, Lily ^b  

^a AMERICAN RED CROSS   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOTOSALEN;

ARTICLE; ASSAY; BLOOD; BLOOD GROUP ABO SYSTEM; IN VITRO STUDY; PH; PLASMA; SHOCK; THROMBOCYTE PRESERVATION; THROMBOCYTE STRUCTURE; ULTRAVIOLET RADIATION;

BLOOD CELL COUNT; BLOOD CHEMICAL ANALYSIS; BLOOD PLATELETS; BLOOD PRESERVATION; CELLS, CULTURED; HUMANS; PLASMA; PLATELETPHERESIS; PSORALENS; TIME FACTORS; ULTRAVIOLET RAYS;

EID: 62949132847     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2008.02040.x     Document Type: Article

References (36)

1. Burstain JM, Brecher ME, Workman K, Foster M, Faber GH, Mair D. Rapid identification of bacterially contaminated platelets using reagent strips: glucose and pH analysis as markers of bacterial metabolism. Transfusion 1997 37 : 255 8.
2. Wagner SJ, Robinette D. Evaluation of swirling, pH, and glucose tests for the detection of bacterial contamination in platelet concentrates. Transfusion 1996 36 : 989 93.
3. Werch JB, Mhawech P, Stager CE, Banez EI, Lichtiger B. Detecting bacteria in platelet concentrates by use of reagent test strips. Transfusion 2002 42 : 1027 31.
4. Clark P, Parsons TM, Boyd JC, Dewey P, Mintz PD. Imported platelets demonstrate decreased pH and glucose by reagent strip testing when compared to locally derived platelets. Ann Clin Lab Sci 2006 36 : 443 6.
5. Tarrand J, Sazama KJ, Lichtiger B. Reagent strips may not detect Staphylococcus epidermidis contamination of platelet concentrates. Arch Pathol Lab Med 2004 128 : 852 3.
6. Sweeney JD, Kouttab NM, Holme S, Kurtis JD, Cheves TA, Nelson EJ. Prestorage pooled whole-blood-derived leukoreduced platelets stored for seven days, preserve acceptable quality and do not show evidence of a mixed lymphocyte reaction. Transfusion 2004 44 : 1212 9.
7. Sweeney JD, Kouttab NM, Penn CL, McHugh KE, Nelson EJ, Oblon DJ. A comparison of prestorage WBC-reduced whole-blood-derived platelets and bedside-filtered whole-blood-derived platelets in autologous progenitor cell transplant. Transfusion 2000 40 : 794 800.
8. Brecher ME, Hay SN, Rose AD, Rothenberg SJ. Evaluation of BacT/ALERT plastic culture bottles for use in testing pooled whole blood-derived leukoreduced platelet-rich plasma platelets with a single contaminated unit. Transfusion 2005 45 : 1512 7.
9. Benjamin RJ, Wagner SJ. The residual risk of sepsis: modeling the effect of concentration on bacterial detection in two-bottle culture systems and an estimation of false-negative culture rates. Transfusion 2007 47 : 1381 9.
10. Murphy WG, Foley M, Doherty C, Tierney G, Kinsella A, Salami A, Cadden E, Coakley P. Screening platelet concentrates for bacterial contamination: low numbers of bacteria and slow growth in contaminated units mandate an alternative approach to product safety. Vox Sang 2008 95 : 13 9.
11. Yomtovian R, Figueroa PI, Wilson DA, Hall GS, Bajaksouzian S, Windau A, Jacobs M. Detection of bacteria in leukocyte-reduced single-donor apheresis platelet units (LR-SDAPs) using the Pan Genera Detection (PGD) assay (Verax Biomedical, Worcester, MA). Transfusion 2007 47S : 37A (abstract S94-040E).
12. Webert KE, Cserti CM, Hannon J, Lin Y, Pavenski K, Pendergrast JM, Blajchman MA. Proceedings of a consensus conference: pathogen inactivation-making decisions about new technologies. Transfus Med Rev 2008 22 : 1 34.
13. McCullough J, Vesole DH, Benjamin RJ, Slichter SJ, Pineda A, Snyder E, Stadtmauer EA, Lopez-Plaza I, Coutre S, Strauss RG, Goodnough LT, Fridey JL, Raife T, Cable R, Murphy S, Howard F 4th., Davis K, Lin JS, Metzel P, Corach L, Koutsoukos A, Lin L, Buchholz DH, Conlan MG. Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial. Blood 2004 104 : 1534 41.
14. van Rhenen D, Gulliksson H, Cazenave JP, Pamphilon D, Ljungman P, Klüter H, Vermeij H Kappers-Klunne M, de Greef G, Laforet M, Lioure B, Davis K, Marblie S, Mayaudon V, Flament J, Conlan M, Lin L, Metzel P, Buchholz D, Corash L. Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroPSRITE trial. Blood 2003 101 : 2426 33.
15. de Alarcon P, Benjamin R, Dugdale M, Kessler C, Shopnick R, Smith P, Abshire T, Hambleton J, Matthew P, Ortiz I, Cohen A, Konkle BA, Streiff M, Lee M, Wages D, Corash L. Fresh frozen plasma prepared with amotosalen HCl (S-59) photochemical pathogen inactivation: transfusion of patients with congenital coagulation factor deficiencies. Transfusion 2005 45 : 1362 72.
16. Mintz PD, Bass NM, Petz LD, Steadman R, Streiff M, McCullough J, Burks S, Wages D, Van Doren S, Corash L. Photochemically treated fresh frozen plasma for transfusion of patients with acquired coagulopathy of liver disease. Blood 2006 107 : 3753 60.
17. Mintz PD, Neff A, MacKenzie M, Goodnough LT, Hillyer C, Kessler C, McCrae K, Menitove JE, Skikne BS, Damon L, Lopez-Plaza I, Rouault C, Crookston KP, Benjamin RJ, George J, Lin JS, Corash L, Conlan MG. A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh-frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpura. Transfusion 2006 46 : 1693 704.
18. Lin L, Hanson CV, Alter HJ, Jauvin V, Bernard KA, Murthy KK, Metzel P, Corash L. Inactivation of viruses in platelet concentrates by photochemical treatment with amotosalen and long-wavelength ultraviolet light. Transfusion 2005 45 : 580 90.
19. Jordan CT, Saakadze N, Newman JL, Lezhava LJ, Maiers TT, Hillyer WM, Roback JD, Hillyer CD. Photochemical treatment of platelet concentrates with amotosalen hydrochloride and ultraviolet A light inactivates free and latent cytomegalovirus in a murine transfusion model. Transfusion 2004 44 : 1159 65.
20. Lin L, Dikeman R, Molini B, Lukehart SA, Lane R, Dupuis K, Metzel P, Corash L. Photochemical treatment of platelet concentrates with amotosalen and long-wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteria. Transfusion 2004 44 : 1496 504.
21. Castro E, Gironés N, Bueno JL, Carrión J, Lin L, Fresno M. The efficacy of photochemical treatment with amotosalen HCl and ultraviolet A (INTERCEPT) for inactivation of Trypanosoma cruzi in pooled buffy-coat platelets. Transfusion 2007 47 : 434 41.
22. Grellier P, Benach J, Labaied M, Charneau S, Gil H, Monsalve G, Alfonso R, Sawyer L, Lin L, Steiert M, Dupuis K. Photochemical inactivation with amotosalen and long-wavelength ultraviolet light of Plasmodium and Babesia in platelet and plasma components. Transfusion 2008 48 : 1676 84.
23. Eastman RT, Barrett LK, Dupuis K, Buckner FS, Van Voorhis WC. Leishmania inactivation in human pheresis platelets by a psoralen (amotosalen HCl) and long-wavelength ultraviolet light. Transfusion 2005 45 : 1459 63.
24. Kunicki TJ, Tuccelli M, Becker GA, Aster RH. A study of variables affecting the quality of platelets stored at room temperature. Transfusion 1975 15 : 414 21.
25. Murphy S. Platelet storage for transfusion. Semin Hematol 1985 22 : 165 77.
26. Holme S, Moroff G, Murphy S. A multi-laboratory evaluation of the in vitro platelet assays: the tests for extent of shape change and response to hypotonic shock. Transfusion 1998 38 : 31 40.
27. Dumont LJ, VandenBroeke T, Ault KA. Platelet surface P-selectin measurements in platelet preparations: an international collaborative study. Biomedical Excellence for Safer Transfusion (BEST) Working Party of the International Society of Blood Transfusion (ISBT). Transfus Med Rev 1999 13 : 31 42.
28. Tschoepe D, Spangenberg P, Esser J, Schwippert B, Kehrel B, Roesen P, Gries FA. Flow-cytometric diction of surface membrane alterations and concomitant changes in the cytoskeletal actin status of activated platelets. Cytometry 1990 11 : 652 6.
29. Snyder EL, Koerner TA Jr., Kakaiya R, Moore P, Kiraly T. Effect of mode of agitation on storage of platelet concentrates in PL-732 containers for 5 days. Vox Sang 1983 44 : 300 4.
30. Picker SM, Speer R, Gathof BS. Functional characteristics of buffy-coat PLTs photochemically treated with amotosalen-HCl for pathogen inactivation. Transfusion 2004 44 : 320 9.
31. Lin L, Cook GP, Wiesehahn R, Alfonso B, Hehraman GD, Cimino L, Corten PB, Damonte R, Kikeman R, Dupuis K, Fang YM, Hanson CV, Hearst JE, Lin CY, Londe HF, Mechette K, Nerio AT, Pu JT, Reames AA, Rheinschmidt J, Tessman ST, Isaacs S, Wollowitz S, Corash L. Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light. Transfusion 1997 37 : 423 35.
32. Knutson F, Alfonso R, Dupuis K, Mayaudon V, Lin L, Corash L, Högman CF. Photochemical inactivation of bacteria and HIV in buffy-coat-derived platelet concentrates under conditions that preserve in vitro platelet function. Vox Sang 2000 78 : 209 16.
33. Wagner SJ, White R, Wolf L, Chapman J, Robinette D, Lawlor TE, Dodd RY. Determination of residual AMT and mutagenicity testing following PUVA treatment of platelet suspensions. Photochem Photobiol 1992 57 : 819 24.
34. Simonsen AC, Johansson PI, Conlan MG, Jacquet M, Lin JS, Junge K, Lin L, Sørensen H, Borregaard N, Flament J. Transfusion of 7-day-old amotosalen photochemically-treated buffy coat platelets to thrombocytopenic patients: a pilot study. Transfusion 2006 46 : 424 33.
35. Brecher ME, Hay S, Corash L, Hsu J, Lin L. Evaluation of bacterial inactivation in pre-storage pooled, leukoreduced, whole blood-derived platelet concentrates suspended in plasma prepared with photochemical treatment. Transfusion 2007 47 : 1896 901.
36. Steiert M, Brussels A, Vandercappellen A, Lin L. Evaluation of viral and bacterial inactivation in platelet concentrates suspended in 100% plasma treated with the INTERCEPT Blood System. Vox Sang 2008 95 Suppl 1 : 301.